These results suggest that metformin inhibits p-PI3K p85 (Tyr199) and p-Akt (ser473) expression; upregulates MICA and p53 expression; and inhibits the growth of cervical cancer xenografts in mice. The gene discussed is AKT1; the disease is cervical cancer.